Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Cigna
CI
$79.6B
| $409M | 0.12% |
1,779,492
+30,257
| +2% | +$6.43M |
|
152
Tyson Foods
TSN
$21.5B
| $407M | 0.12% |
4,671,782
+175,358
| +4% | +$14.4M |
|
|
MRSH
153
Marsh
MRSH
$91.7B
| $406M | 0.12% |
2,336,976
+46,757
| +2% | +$7.77M |
|
154
CSX Corp
CSX
$94.2B
| $403M | 0.12% |
10,727,603
+193,011
| +2% | +$6.81M |
|
155
Moderna
MRNA
$22.1B
| $400M | 0.12% |
1,573,486
+35,670
| +2% | +$10.4M |
|
156
Chubb
CB
$141B
| $399M | 0.12% |
2,061,599
+26,102
| +1% | +$4.9M |
|
157
Schwab US REIT ETF
SCHH
$11.7B
| $398M | 0.12% |
15,099,588
-8,924
| -0.1% | -$220K |
|
158
Oneok
OKE
$55.9B
| $397M | 0.12% |
6,761,684
+246,454
| +4% | +$15.3M |
|
159
Edwards Lifesciences
EW
$48.2B
| $392M | 0.12% |
3,024,247
+85,550
| +3% | +$9.98M |
|
160
Northern Trust
NTRS
$22.2B
| $373M | 0.11% |
3,117,127
+119,649
| +4% | +$14.3M |
|
161
Realty Income
O
$61.3B
| $373M | 0.11% |
5,207,762
+1,620,341
| +45% | +$111M |
|
162
CME Group
CME
$93.5B
| $371M | 0.11% |
1,623,775
+42,571
| +3% | +$9.37M |
|
163
Novartis
NVS
$304B
| $368M | 0.11% |
4,205,694
+89,226
| +2% | +$7.41M |
|
164
Hartford Financial Services
HIG
$39.3B
| $366M | 0.11% |
5,305,298
+82,472
| +2% | +$5.82M |
|
165
Arthur J. Gallagher & Co
AJG
$68.2B
| $365M | 0.11% |
2,153,532
+124
| +0% | +$20.3K |
|
166
Southern Company
SO
$109B
| $361M | 0.11% |
5,262,209
+215,180
| +4% | +$13.7M |
|
167
Vanguard Dividend Appreciation ETF
VIG
$113B
| $357M | 0.11% |
2,078,748
+102,546
| +5% | +$16.9M |
|
168
Best Buy
BBY
$18.9B
| $354M | 0.1% |
3,484,436
+150,628
| +5% | +$17.1M |
|
169
Welltower
WELL
$175B
| $353M | 0.1% |
4,110,249
+197,780
| +5% | +$16.5M |
|
170
Regeneron Pharmaceuticals
REGN
$72.9B
| $351M | 0.1% |
556,294
+26,766
| +5% | +$16.5M |
|
171
Intercontinental Exchange
ICE
$86.4B
| $349M | 0.1% |
2,554,250
+69,337
| +3% | +$9.19M |
|
172
Watsco Inc
WSO
$15.1B
| $348M | 0.1% |
1,113,795
+15,572
| +1% | +$4.61M |
|
173
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
| $348M | 0.1% |
6,594,901
+193,604
| +3% | +$10.3M |
|
174
Norfolk Southern
NSC
$76.1B
| $348M | 0.1% |
1,170,212
+20,414
| +2% | +$5.7M |
|
175
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
| $346M | 0.1% |
5,838,790
+1,353,442
| +30% | +$80.6M |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.